Skip to content

Site logo

Main menu
  • Company
    • Who we are
    • What we do
    • Stories
    • History
    • Sustainability
      • Sustainability overview
      • Philanthropy
      • Merck Medical Outreach Program
      • Impact Venture Fund
      • Transparency disclosures
      • Sustainability resources
    • Leadership
      • Leadership overview
      • Board of directors
      • Executive team
    • Culture & values
      • Culture & values overview
      • Code of conduct, ethics & compliance
    • Diversity and inclusion
    • Policies and positions
    • Suppliers
      • Suppliers overview
      • Supplier registration
      • Supplier help for Ariba
  • Research
    • Research overview
    • Areas of focus
      • Oncology
      • Vaccines
      • Infectious diseases
      • Cardio-metabolic disorders
      • Immunology
      • Neuroscience
      • Ophthalmology
    • Areas of innovation
      • Data science and artificial intelligence 
      • Green and sustainable science
      • Our therapeutic modalities
      • Translational medicine
    • Pipeline
    • Business development and licensing (BD&L)
    • Clinical trials
      • Clinical trials overview
      • Find a trial
      • Diversity in clinical trials
    • R&D locations
    • How we invent
    • Meet our scientists
    • Publications
  • Products
    • Products list
    • Safety data sheets
    • Product patents
    • Merck authorized distributors
  • Patients
    • Patients overview
    • Patient support programs
    • Play an active role in your health care
  • Investors
    • Investors overview
    • Events & presentations
    • Financial information
      • Financial information overview
      • SEC filings
    • Stock information
    • Investor resources
  • Media
    • Media overview
    • News releases
    • Company statements
    • Media library & contacts
    • Company fact sheet
  • Careers
Scientist reviewing test tubes

Who we are

Learn more
Contact us

What can we help you find?

Search for:

Merck & Co., Inc. Q3 2023 Earnings Call

Merck & Co., Inc. Announced Collaboration with Daiichi Sankyo and ESMO Investor Event

Merck & Co., Inc. at the Morgan Stanley 21st Annual Global Healthcare Conference

Merck & Co., Inc. at the Citi 18th Annual BioPharma Conference

Merck & Co., Inc. Q2 2023 Earnings Call

Merck & Co., Inc. at the Goldman Sachs 44th Annual Global Healthcare Conference

Merck & Co., Inc. Investor Event at ASCO 2023

Merck & Co., Inc. 2023 Annual Meeting of Shareholders

Virtual-only Meeting:
http://www.virtualshareholdermeeting.com/MRK2023

We have adopted a virtual format for the 2023 Annual Meeting of Shareholders to provide a convenient and consistent experience to all shareholders regardless of location.

Merck & Co., Inc. at the Bank of America Securities 2023 Healthcare Conference

Merck & Co., Inc. Q1 2023 Earnings Call

Posts navigation

Older posts
Newer posts

  • What can we help you find?

    Search for:

  • Pages

    • Careers
    • Certification of products subject to the requirements of the Consumer Product Safety Improvement Act of 2008 (CPSIA)
    • Contact us
    • Copyright
    • Forward-looking statement
    • ical
    • Merck | Home
    • Products list
      • Safety data sheets
      • Product patents
      • Authorized distributors
    • Responsible Vulnerability Disclosure Program of Merck & Co., Inc., Rahway, NJ, USA
    • Sitemap
    • Stories
    • Terms of use
    • What we do
      • Manufacturing
      • The journey of a molecule
    • Who we are
      • History
      • Sustainability
        • Access to health
        • Environmental sustainability
        • Impact Venture Fund
        • Merck Medical Outreach Program
        • Philanthropy
          • Advancing equity in cancer care
          • Advancing patient-centered cancer care
          • Advancing patient-centered cancer care in resource-limited countries
          • Enhancing diabetes care through community outreach and support
          • Expanding access to cancer care in Asia
          • Global emergency response
          • Improving access to high-quality diabetes care
          • Improving access to HIV care in sub-Saharan Africa
          • Improving health care access
          • Merck Foundation
          • Patient assistance and product donation programs
          • Promoting equity in HIV/AIDS care in the Southeastern U.S.
          • Richard T. Clark Fellowship for Global Health
          • Solutions for Healthy Communities
          • Strengthening health systems’ resilience through immunization
          • Strengthening our communities
        • Sustainability resources
        • Transparency disclosures
      • Leadership
        • Board of directors
        • Executive team
      • Culture & values
        • Code of conduct, ethics & compliance
          • Code of conduct – Values & standards
          • Business partner code of conduct
      • Diversity and inclusion
        • Diversity and inclusion initiatives
          • Disability inclusion
          • Employee business resource groups
          • Global diversity and inclusion ambassador teams
        • Diversity and inclusion partners
        • Diversity and inclusion strategy
      • Policies and positions
      • Suppliers
        • Economic inclusion and small business development
        • What we buy
    • Research
      • Areas of focus
      • Areas of innovation
        • Data science and artificial intelligence 
        • Green and sustainable science
          • Green chemistry programs and initiatives
        • Our therapeutic modalities
        • Translational medicine
      • Business development and licensing (BD&L)
        • Collaborate with us
        • News
      • CHLOR-TRIMETON
      • Immunology
      • Meet our scientists
      • Neuroscience
      • Ophthalmology
      • Our science in action
      • Postdoctoral research fellows program
      • Publications
      • Scientific capabilities
      • Vaccines
      • Infectious diseases
        • HIV
      • Oncology
      • Cardio-metabolic diseases
      • Pipeline
      • Discovery & development
        • Ethical treatment of animals
      • Clinical trials
      • Diversity in clinical trials
      • R&D locations
    • Patients
      • Patient support programs
      • Play an active role in your health care
        • Caregiver support
        • Make the most of your doctor’s visit
        • Medicine safety tips
    • Investor relations
      • Email alerts
      • Email alerts
      • Email alerts
      • Events & presentations
      • Financial information
        • SEC filings
      • Stock information
      • Investor resources
        • Request for information
    • Media
      • Company fact sheet
      • Manufacturing media library
      • News releases
      • Company statements
      • Media library & contacts

  • Archives

  • Categories

    • No categories

  • Meta

    • Log in

Connect with us on social

social icon social icon social icon social icon social icon
  • MerckHelps
    Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.
  • Merck Access Program
    Information about insurance coverage and financial assistance options for eligible patients.
  • Clinical trials
    Learn about our clinical trials and find available studies.
  • Merck Manuals
    Medical information source covering thousands of topics in all fields of medicine.
  • Impact Report
    Reporting on our commitment to operating responsibly to benefit society.
  • Merck for Mothers
    An initiative to create a world where no woman has to die giving life.
  • Merck Animal Health
    The global animal health business unit of Merck.
  • Health Plan - Transparency in Coverage
    In compliance with the Consolidated Appropriations Act, learn more about our health plan’s pricing information.
  • Contact Us
    If you have a question or need more information about us, find out who you should contact.
  • Forward-looking statement
  • Cookie policy
  • Privacy
  • Transparency disclosure
  • Terms of use
  • Accessibility
  • Sitemap
  • Consumer Health Data Privacy Policy
  • Your Privacy Choices
Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
Accessibility icon View Privacy Shield Verification Status View APEC CBPR Privacy Certification Status

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.


Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue